Cui, Haotian
Maan, Hassaan
Vladoiu, Maria C.
Zhang, Jiao
Taylor, Michael D.
Wang, Bo http://orcid.org/0000-0002-9620-3413
Funding for this research was provided by:
Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-06189)
Natural Sciences and Engineering Research Council of Canada (DGECR-2020-00294)
Canadian Institute for Advanced Research
Article History
Received: 26 September 2023
Accepted: 18 December 2023
First Online: 19 January 2024
Declarations
:
: Not applicable - ethical approval was not needed for the study, as publicly available datasets were used. No private, confidential, or sensitive information pertaining to individuals was utilized. Furthermore, our research did not involve any animal experiments.
: All authors have reviewed and consented to the publication of this manuscript.
: Bo Wang is on the Strategic Advisory Board of Vevo Therapeutics Inc. The remaining authors declare no competing interests.